App: Johns Hopkins Antibiotic Guide
Developer: Unbound Medicine, Inc.
Genres: Medical, Health & Fitness

The Johns Hopkins Guides provide:
• Evidence-based recommendations
• Expert analysis and commentary
• Important literature references -- with abstracts and links to full-text articles
• Webinars from Johns Hopkins content experts
• Monthly content updates

ANTIBIOTIC (ABX) GUIDE FEATURES: 
• Hundreds of detailed Antimicrobial Drug listings
• In-depth sections on Forms, Dosing, Spectrum, Resistance, Adverse Reactions, and Interactions
• Comprehensive Disease, Pathogen, Management, and Vaccine topics

PSYCHIATRY GUIDE FEATURES: 
• Hundreds of detailed psychiatry topics
• Fast access to Symptoms, Differential Diagnoses, Treatments and When to Refer
• Expert correlation with the DSM-5 classification

HIV GUIDE FEATURES: 
• Hundreds of HIV-specific topics 
• Point-of-need access to Diseases, Drugs, and Management 
• HIV Drug listings with Dosing, Adverse Reactions, and Drug Interactions

DIABETES GUIDE FEATURES: 
• Hundreds of specialized Diabetes topics 
• Evidence-based details on Diagnoses, Tests, Drugs, and Complications
• Special coverage of specific populations  

UNBOUND APP FEATURES: 
• Enhanced Search to find topics quickly 
• “Favorites” for bookmarking important entries 
• Highlighting and note-taking within entries 
• Access to the official HopkinsGuides.com website

TRIAL / SUBSCRIPTION DETAILS
• New users can access any of the Johns Hopkins Guides free for 30 days.
• After 30 days, your iTunes account will be charged $29.99 for a one-year subscription to each trialed Guide (or $79.99 for the 4-Guide Bundle) unless you have turned off auto-renew in Account Settings at least 24 hours before the free trial ends.
• At the end of the one-year period, your subscription will automatically renew unless auto-renew is turned off in Account Settings 24 hours prior to the renewal date.
• If you choose not to renew, you will still be able to use the app but will not receive medication updates

Publisher: Johns Hopkins Medicine
Powered by: Unbound Medicine

Unbound Privacy Policy: https://www.unboundmedicine.com/privacy
Unbound Terms of Use: https://www.unboundmedicine.com/end_user_license_agreement

Release notes:
• Includes HopkinsGuides.com access
• Monthly updates - latest topics added/revised: 
-- Rebyota - New fecal microbiota transplantation drug that is indicated for the prevention of recurrence of Clostridioides difficile infection (CDI). 
-- Influenza - All influenza modules updated to reflect the 2023–24 Influenza Season. 
-- Peripheral Neuropathy - The addition of several biomarkers that can be used for the diagnosis and management of neuropathic pain. 
-- Immunomodulating Therapies in Type 1 Diabetes - Includes newly added clinical treatments and nutritional interventions. 
-- Clostridioides (ex. Clostridium) difficile - Two FDA-approved donor-derived products for treatment. 
-- Prototheca wickerhamii - Pathogen that is now seen more in the southeast section of the US.